Abstract
We present our preliminary results. Of 30 patients with M1 renal cell carcinoma, 21 were included in our prospective controlled pilot study until March 14, 1992. These 21 patients were evaluated for efficacy in the treatment with recombinant interferon alfa-2b in combination with 5-fluorouracil (5-FU).
Keywords
- Renal Cell Carcinoma
- Bone Metastasis
- Karnofsky Performance Status
- Soft Tissue Metastasis
- Interferon Alpha Therapy
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAuthor information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Goldschmidt, A.J.W., Tunn, U.W. (1994). Response According to Site of Metastases in Patients with Metastatic RCC (Renal Cell Carcinoma) During Treatment with Interferon Alpha in Combination with 5-Fluorouracil. In: Staehler, G., Pomer, S. (eds) Contemporary Research on Renal Cell Carcinoma. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78609-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-78609-9_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78611-2
Online ISBN: 978-3-642-78609-9
eBook Packages: Springer Book Archive